D-0600-2024 Class II Terminated
FDA drug recall D-0600-2024 was initiated by Zydus Pharmaceuticals (USA) Inc on June 27, 2024 and is designated Class II. Reason for recall: Presence of particulate matter: glass The recall status is terminated (terminated September 4, 2025). Affected quantity: 432250 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- July 24, 2024
- Initiation Date
- June 27, 2024
- Termination Date
- September 4, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 432250 vials
Product Description
Cyanocobalamin Injection, USP, 1,000mcg/mL, 1 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN, 38141, Mfd. in India, NDC 16714-165-01.
Reason for Recall
Presence of particulate matter: glass
Distribution Pattern
TN
Code Information
Lot #: L200253, L200281, L200301, Exp 07/31/2024